Equity Research, Broker Reports, and media content on Bavarian Nordic

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Bavarian Nordic
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Bavarian Nordic. We currently have 4 research reports from 1 professional analysts.

Open
N/A
Range Today
N/A
52 Week
18300/44400c
Daily Volume
N/A
# Shares
0m
Daily Liquidity
0.0%
Pension Liability
Enterprise Value
n/am
Market Cap
7,903m
Latest PE (hist)
Div Yield
Date Source Announcement
21Mar19 06:46 GNW Bavarian Nordic Announces Annual Report 2018
21Feb19 18:33 GNW Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
18Jan19 06:14 GNW Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN® Smallpox Vaccine
21Dec18 20:28 GNW Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
09Nov18 06:48 GNW Bavarian Nordic Announces Interim Results for the First Nine Months of 2018
02Nov18 16:30 GNW Bavarian Nordic to Host Third Quarter 2018 Results Conference Call
02Nov18 13:55 GNW Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
  • Frequency of research reports

     

  • Research reports on

    Bavarian Nordic

  • Providers covering

    Bavarian Nordic